Leaflet ROVAMYCINE 1.5MUI film-coated tablets
Indicated for: bacterial infections
Substance: spiramycin (macrolide antibiotic)
ATC: J01FA02 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins)
Spiramycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria. It is effective against respiratory infections, skin and soft tissue infections, but is particularly used for the prevention and treatment of toxoplasmosis in pregnant women to reduce the risk of transmission to the fetus.
It is administered orally, usually in tablet form, or intravenously, depending on the severity of the infection. The dosage and duration of treatment are determined by the doctor based on the type and severity of the infection.
Common side effects include nausea, vomiting, diarrhea, abdominal pain, and allergic reactions such as skin rashes. In rare cases, it may cause more severe reactions, such as hepatotoxicity or severe allergic responses.
Spiramycin is contraindicated in individuals with hypersensitivity to macrolides. It is important for patients to strictly follow their doctor's instructions and not discontinue treatment prematurely to prevent the development of bacterial resistance.
General data about ROVAMYCINE 1.5MUI
- Substance: spiramycin
- Date of last drug list: 01-05-2026
- Commercial code: W63533001
- Concentration: 1.5MUI
- Pharmaceutical form: film-coated tablets
- Quantity: 16
- Product type: original
- Price: 13.36 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for spiramycin
- 1.5MUI
- 3MUI